AAAAAA

   
Results: 1-7 |
Results: 7
INHIBITION OF GROWTH OF ANDROGEN-INDEPENDENT DU-145 PROSTATE-CANCER IN-VIVO BY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONISTS RC-3940-II AND RC-3950-II
Authors: JUNGWIRTH A PINSKI J GALVAN G HALMOS G SZEPESHAZI K CAI RZ GROOT K VADILLOBUENFIL M SCHALLY AV
Citation: A. Jungwirth et al., INHIBITION OF GROWTH OF ANDROGEN-INDEPENDENT DU-145 PROSTATE-CANCER IN-VIVO BY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONISTS RC-3940-II AND RC-3950-II, European journal of cancer, 33(7), 1997, pp. 1141-1148
INHIBITION OF IN-VIVO PROLIFERATION OF ANDROGEN-INDEPENDENT PROSTATE CANCERS BY AN ANTAGONIST OF GROWTH HORMONE-RELEASING HORMONE
Authors: JUNGWIRTH A SCHALLY AV PINSKI J HALMOS G GROOT K ARMATIS P VADILLOBUENFIL M
Citation: A. Jungwirth et al., INHIBITION OF IN-VIVO PROLIFERATION OF ANDROGEN-INDEPENDENT PROSTATE CANCERS BY AN ANTAGONIST OF GROWTH HORMONE-RELEASING HORMONE, British Journal of Cancer, 75(11), 1997, pp. 1585-1592
INHIBITION OF GROWTH OF HUMAN SMALL-CELL AND NONSMALL CELL LUNG CARCINOMAS BY ANTAGONISTS OF GROWTH HORMONE-RELEASING HORMONE (GH-RH)
Authors: PINSKI J SCHALLY AV JUNGWIRTH A GROOT K HALMOS G ARMATIS P ZARANDI M VADILLOBUENFIL M
Citation: J. Pinski et al., INHIBITION OF GROWTH OF HUMAN SMALL-CELL AND NONSMALL CELL LUNG CARCINOMAS BY ANTAGONISTS OF GROWTH HORMONE-RELEASING HORMONE (GH-RH), International journal of oncology, 9(6), 1996, pp. 1099-1105
DOWN-REGULATION OF PITUITARY RECEPTORS FOR LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) IN RATS BY LH-RH ANTAGONIST CETRORELIX
Authors: HALMOS G SCHALLY AV PINSKI J VADILLOBUENFIL M GROOT K
Citation: G. Halmos et al., DOWN-REGULATION OF PITUITARY RECEPTORS FOR LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) IN RATS BY LH-RH ANTAGONIST CETRORELIX, Proceedings of the National Academy of Sciences of the United Statesof America, 93(6), 1996, pp. 2398-2402
CHRONIC ADMINISTRATION OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) ANTAGONIST CETRORELIX DECREASES GONADOTROPE RESPONSIVENESS AND PITUITARY LHRH RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS IN RATS
Authors: PINSKI J LAMHARZI N HALMOS G GROOT K JUNGWIRTH A VADILLOBUENFIL M KAKAR SS SCHALLY AV
Citation: J. Pinski et al., CHRONIC ADMINISTRATION OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) ANTAGONIST CETRORELIX DECREASES GONADOTROPE RESPONSIVENESS AND PITUITARY LHRH RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS IN RATS, Endocrinology, 137(8), 1996, pp. 3430-3436
LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AS PRIMARY SINGLE THERAPY IN PATIENTS WITH ADVANCED PROSTATIC-CANCER AND PARAPLEGIA DUE TO METASTATIC INVASION OF SPINAL-CORD
Authors: GONZALEZBARCENA D VADILLOBUENFIL M CORTEZMORALES A FUENTESGARCIA M CARDENASCORNEJO I COMARUSCHALLY AM SCHALLY AV
Citation: D. Gonzalezbarcena et al., LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AS PRIMARY SINGLE THERAPY IN PATIENTS WITH ADVANCED PROSTATIC-CANCER AND PARAPLEGIA DUE TO METASTATIC INVASION OF SPINAL-CORD, Urology, 45(2), 1995, pp. 275-281
RESPONSES TO THE ANTAGONISTIC ANALOG OF LH-RH (SB-75, CETRORELIX) IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC-CANCER
Authors: GONZALEZBARCENA D VADILLOBUENFIL M GOMEZORTA F GARCIA MF CARDENASCORNEJO I GRAEFSANCHEZ A COMARUSCHALLY AM SCHALLY AV
Citation: D. Gonzalezbarcena et al., RESPONSES TO THE ANTAGONISTIC ANALOG OF LH-RH (SB-75, CETRORELIX) IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC-CANCER, The Prostate, 24(2), 1994, pp. 84-92
Risultati: 1-7 |